Closed Devlin-Moyer closed 5 months ago
3(S)-Phytanoyl-CoA (MAM03362c and MAM03362x) and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363x) seem to be entirely redundant with phytanoyl-CoA (MAM02747c and MAM02747x) and 2-hydroxyphytanoyl-CoA (MAM00655x)
@Devlin-Moyer if you have more evidence demonstrating that 3(S)-Phytanoyl-CoA (MAM03362c and MAM03362x) and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363x) are the same?
@Christoff1993 if you can help to double check this?
sorry I may not have written that super clearly; 3(S)-Phytanoyl-CoA (MAM03362
) is the same as phytanoyl-CoA (MAM02747
), and 3(S)-2-Hydroxyphytanoyl-CoA (MAM03363
) is the same as 2-hydroxyphytanoyl-CoA (MAM00655
)
I just came across this paper that mentions that people's diets usually consist of a racemic mixture of (3S)- and (3R)-phytanic acid, and while the enzymes responsible for the alpha-oxidation of phytanic acid to pristanal recognize either enantiomer, ACOX2 and ACOX3 (the enzymes responsible for the first step of beta-oxidation of pristanic acid) only act on 2S-pristanoyl-CoA, so people born with defective AMACR (the enzyme responsible for converting 2R-pristanoyl-CoA into 2S-pristanoyl-CoA) accumulate 2R-pristanic acid in their blood.
At the moment, it seems like MAM02746
, MAM02747
, and MAM00655x
represent racemic phytanic acid, phytanoyl-CoA, and 2-hydroxyphytanoyl-CoA, and no metabolites that are currently present in Human-GEM specifically represent the 3R enantiomers. The stereochemistry gets even more confusing with the metabolites representing pristanal, pristanic acid, and pristanoyl-CoA; 2S-pristanal (MAM00564x
) becomes (racemic?) pristanic acid (MAM02766x
) in MAR03386
, which can become 2S-pristanoyl-CoA (MAM00078x
) in MAR03387
, 2R-pristanoyl-CoA (MAM00075x
) in MAR03493
, or (racemic?) pristanoyl-CoA (MAM03887x
) in MAR05183
. The changes I proposed in the initial comment would basically remove any semblance of stereospecificity in this pathway; if we instead wanted to represent each enantiomer with a separate metabolite, we should:
MAM02746e
, MAM02746c
and MAM02746x
to "(3R)-phytanic acid"MAM02747c
and MAM02747x
to "(3R)-phytanoyl-CoA"MAM00655x
to "(3R)-2-hydroxyphytanoyl-CoA"MAM00564x
) with the new (2R)-pristanal metabolite in MAR03486
MAM00077x
), MAR03488
, and MAR03489
(they were removed in #519)MAM00564x
) with the new (2R)-pristanal metabolite in MAR03488
MAM00078x
) with (2R)-pristanoyl-CoA (MAM00075x
) in MAR03489
MAM02746c
with the new cytosolic (3S)-phytanic acid metabolite in MAR03388
MAM03362
)MAM03362c
, MAM03362x
, MAM03363x
, MAR03384
, and MAR03385
exactly as they are (i.e. instead of removing them, as initially proposed in this issue)MAR03389
(currently converts phytanic acid (MAM02746x
) to 3S-phytanoyl-CoA (MAM03362x
); MAR03482
converts phytanic acid (MAM02746x
) to phytanoyl-CoA (MAM02747x
), so if we rename both of those to (3R)-phytanic acid and (3R)-phytanoyl-CoA, we only want to keep MAR03482
)MAR05186
and MAR05187
(I already proposed this in #775 since they duplicate MAR03486
+ MAR03386
in addition to being ambiguous about stereochemistry)This would create two fully distinct series of metabolites and reactions for representing each pair of enantiomers that converge at MAR03491
, which already interconverts (2R)-pristanoyl-CoA (MAM00075x
) and (2S)-pristanoyl-CoA (MAM00078x
):
Reaction | ID using S-enantiomers | ID using R-enantiomers |
---|---|---|
Exchange of phytanic acid | new | MAR09037 |
Transport of phytanic acid from [e] to [c] | new | MAR00440 |
Transport of phytanic acid from [c] to [x] | not sure if necessary | MAR03478 |
Phytanic acid to phytanoyl-CoA in [c] | MAR03388 |
MAR06779 |
Transport of phytanoyl-CoA from [c] to [x] | new | MAR03481 |
Phytanic acid to phytanoyl-CoA in [x] | not sure if necessary | MAR03482 |
Phytanoyl-CoA to 2-hydroxyphytanoyl-CoA | MAR03384 |
MAR03484 |
2-hydroxyphytanoyl-CoA to pristanal | MAR03385 |
MAR03486 |
Pristanal to pristanic acid | MAR03386 |
MAR03488 |
Pristanic acid to pristanoyl-CoA | MAR03387 |
MAR03489 |
Metabolite | S-enantiomer | R-enantiomer |
---|---|---|
Phytanic acid | new | MAM02746 |
Phytanoyl-CoA | MAM03362 |
MAM02747 |
2-Hydroxyphytanoyl-CoA | MAM03363 |
MAM00655 |
Pristanal | MAM00564 |
new |
Pristanic acid | MAM02766 |
MAM00077 |
Pristanoyl-CoA | MAM00078 |
MAM00075 |
I edited the proposed changes to try and accurately reflect the stereochemistry that's relevant to these reactions
I have checked the reasoning and citations, and everything seems comprehensive and sound: all the indicated ambiguities do indeed exist and the proposed changes will solve them. I have no disagreements/additional suggestions.
Current behavior:
Human-GEM's representation of the stereochemistry of phytanic acid metabolites is inconsistent: some metabolites clearly specifically represent the (3S) enantiomers, while others seem to represent racemic mixtures of the (3S) and (3R) enantiomers:
MAM02746
MAM02747
MAM03362
MAM00655
MAM03363
MAM00564
MAM02766
MAM03884
MAM00078
MAR03480
MAR03388
MAR03478
MAR06779
andMAR03481
MAR03482
MAR03389
MAR03484
MAR03384
MAR03486
MAR03385
MAR03386
MAR05183
MAR03387
Expected feature/value/output:
Apparently, most people's diets contain both (3S) and (3R)-phytanic acid, and while the enzymes responsible for the alpha-oxidation of phytanic acid (i.e. the enzymes responsible for the reactions mentioned in this issue) work with either enantiomer, the enzymes responsible for the beta-oxidation of pristanoyl-CoA only recognize (2S)-pristanoyl-CoA, so people who are born with defective AMACR (the enzyme responsible for converting (2R)-pristanoyl-CoA into (2S)-pristanoyl-CoA) can only fully metabolize (3S)-phytanic acid and accumulate (2R)-pristanic acid in their blood (source). In order to properly reflect this, I think the unspecified/racemic phytanic acid metabolites should be edited to instead represent the (3R)-enantiomers, and the reactions involving these two sets of metabolites should be fully separated from each other up until
MAR03491
, which already represents the isomerization of (2R)-pristanoyl-CoA and (2S)-pristanoyl-CoA by AMACR:MAM03884
MAM02746
MAM03362
MAM02747
MAM03363
MAM00655
MAM00564
MAM02766
MAM00077
MAM00078
MAM00075
MAR00659
MAR09037
MAR01617
MAR00440
MAR03388
MAR03480
MAR06779
MAR03481
MAR03389
MAR03482
MAR03384
MAR03484
MAR03385
MAR03486
MAR03386
MAR03488
MAR03387
MAR03493
I noticed that #646 removed the
MAM03884
metabolites and all associated reactions for being duplicates of theMAM02746
metabolites, since both sets represent(ed) phytanic acid. I'm proposing to bring back theMAM03884
metabolites and reactions so that they can represent (3R)-phytanic acid, so that we can edit theMAM02746
metabolites and reactions to specifically represent (3S)-phytanic acid.MAR03481
andMAR06779
both represent transport of phytanoyl-CoA from the cytosol into peroxisomes, but onlyMAR06779
correctly represents that this is an ATP-dependent process mediated by ABCD3 (source). Since they both use the racemic phytanoyl-CoA metabolite (MAM02747
), and there is no equivalent reaction using (2S)-phytanoyl-CoA (MAM03362
), I'm proposing to edit both reactions so that they both represent ATP-dependent import, but one uses (2S)-phytanoyl-CoA and the other uses (2R)-phytanoyl-CoA. Also it turns out that ABCD3 probably removes the CoA from its substrates just before it transports them across the peroxisomal membrane (source), so I'm also accounting for that in my proposed changes.Proposed changes:
MAM02746e
,MAM02746c
andMAM02746x
to "(3R)-phytanic acid"MAM03884e
,MAM03884c
andMAM03884x
and rename them to "(3S)-phytanic acid"MAR00659
andMAR01617
(exchange and [e] <-> [c] transport reactions forMAM03884
)MAM02747c
andMAM02747x
to "(3R)-phytanoyl-CoA"MAM02746c
withMAM03884c
inMAR03388
MAR03481
to beMAM02747c + MAM01371c + 2 MAM02040c -> MAM02746x + MAM01597c + MAM02039c + MAM01285c + MAM02751c
, GPR:ENSG00000117528
, references:PMID:24333844;PMID:33500543
MAR06779
to beMAM03362c + MAM01371c + 2 MAM02040c -> MAM03384x + MAM01597c + MAM02039c + MAM01285c + MAM02751c
, GPR:ENSG00000117528
, references:PMID:24333844;PMID:33500543
MAM02746x
withMAM03884x
inMAR03389
MAM00655x
to "(3R)-2-hydroxyphytanoyl-CoA"MAM00564x
) with the new (2R)-pristanal metabolite inMAR03486
MAM02766e
,MAM02766c
, andMAM02766x
to "(2S)-pristanic acid"MAR03488
andMAM00077x
, but replaceMAM00564x
with the new (2R)-pristanal metabolite inMAR03488
MAM02766x
withMAM00077x
inMAR03493
MAM00077c
andMAM00077e
to represent cytosolic and extracellular (2R)-pristanic acidMAM02766c
withMAM00077c
inMAR03390
MAR11966
andMAR11967
but withMAM00077c
andMAM000077e
instead ofMAM02766c
andMAM02766e
These changes don't address the existence of Pristanoyl Coenzyme A (
MAM03887
) in addition to (2S)-pristanoyl-CoA (MAM00078
) and (2R)-pristanoyl-CoA (MAM00075
); that's taken care of in #776